First Page | Meta Content | |
---|---|---|
Document Date: 2009-04-02 11:01:55Open Document File Size: 106,00 KBShare Result on FacebookCityRockville / Montville / /CompanyS-024 Bayer Pharmaceuticals Corporation / Bayer Pharmaceuticals Corporation / /EventFDA Phase / /FacilityNational Library of Medicine / /IndustryTermsupplemental new drug applications / shipped product / printing / supplemental applications / healthcare / drug products / /MedicalConditionTendinopathy / severe tendon disorders / tendinitis / severe tendon disorder / tendonitis / rheumatoid arthritis / pain / tendon disorders / serious tendon disorders / renal failure / inflammation / /MedicalTreatmentlung transplants / /MoviePage 3 3 / /OrganizationFood and Drug Administration / Special Pathogen and Transplant Products Office / Antimicrobial Products Center for Drug Evaluation and Research Enclosure / DEPARTMENT OF HEALTH / Division of Special Pathogen / /PersonRenata Albrecht / Janet Herrington / Kristen Miller / / /PositionDirector / physician / Deputy Director / Regulatory Affairs P.O. Box / Safety Regulatory Project Manager / M.D. Director / /ProductCIPRO XR / ciprofloxacin hydrochloride / Dextrose / CIPRO / ciprofloxacin / Oral Suspension / S-068 / NDA / S-049 / S068 / S-042 / S-026 / S-024 / date / HFD-001 / /ProvinceOrStateNew Jersey / Maryland / /URLhttp /SocialTag |